Compare SKT & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKT | NVST |
|---|---|---|
| Founded | 1981 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.8B |
| IPO Year | 1994 | 2019 |
| Metric | SKT | NVST |
|---|---|---|
| Price | $37.40 | $24.50 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 15 |
| Target Price | ★ $40.20 | $28.69 |
| AVG Volume (30 Days) | 913.0K | ★ 2.8M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | ★ 3.40% | N/A |
| EPS Growth | N/A | ★ 104.31 |
| EPS | 0.53 | ★ 0.56 |
| Revenue | N/A | ★ $2,566,500,000.00 |
| Revenue This Year | $1.24 | $5.79 |
| Revenue Next Year | $3.41 | $3.64 |
| P/E Ratio | $69.27 | ★ $41.96 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $31.13 | $18.77 |
| 52 Week High | $42.53 | $30.42 |
| Indicator | SKT | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 62.55 | 57.00 |
| Support Level | $34.97 | $24.21 |
| Resistance Level | $37.61 | $28.02 |
| Average True Range (ATR) | 0.61 | 0.70 |
| MACD | 0.26 | 0.24 |
| Stochastic Oscillator | 97.85 | 89.58 |
Tanger Inc is an owner and operator of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.